NCT06214468View on ClinicalTrials.gov

Protective Effect of Nicotinamide Riboside Against Acetaminophen Toxicity

PHASE1RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 15, 2024

Primary Completion Date

June 15, 2024

Study Completion Date

April 30, 2025

Conditions
Drug Toxicity
Interventions
COMBINATION_PRODUCT

Acetaminophen and Nicotinamide Riboside

Collection of urine at different time intervals following ingestion of Tylenol plus Nicotinamide Riboside

DRUG

Acetaminophen

Collection of urine at different time intervals following ingestion of Tylenol only

Trial Locations (1)

36604

RECRUITING

University of South Alabama, Mobile

All Listed Sponsors
collaborator

National Aeronautics and Space Administration (NASA)

FED

collaborator

University of Nevada, Las Vegas

OTHER

collaborator

University of Alabama at Birmingham

OTHER

collaborator

Rutgers University

OTHER

lead

University of South Alabama

OTHER